|
1
|
Fendrich V and Bartsch DK: Surgical
treatment of gastrointestinal neuroendocrine tumors. Langenbecks
Arch Surg. 396:299–311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hauso O, Gustafsson BI, Kidd M, Waldum HL,
Drozdov I, Chan AK and Modlin IM: Neuroendocrine tumor
epidemiology: contrasting Norway and North America. Cancer.
113:2655–2664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A and Evans
DB: One hundred years after ‘carcinoid’: epidemiology of and
prognostic factors for neuroendocrine tumors in 35,825 cases in the
United States. J Clin Oncol. 26:3063–3072. 2008.
|
|
4
|
Rindi G, Falconi M, Klersy C, Albarello L,
Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A,
Doglioni C, Delle FG, Fischer L, Fusai G, de Herder WW, Jann H,
Komminoth P, de Krijger RR, La RS, Luong TV, Pape U, Perren A,
Ruszniewski P, Scarpa A, Schmitt A, Solcia E and Wiedenmann B: TNM
staging of neoplasms of the endocrine pancreas: results from a
large international cohort study. J Natl Cancer Inst. 104:764–777.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO Classification of Tumours of the Digestive System.
3. 4th edition. International Agency for Research on Cancer (IARC);
Lyon: 2010
|
|
6
|
Rindi G and Wiedenmann B: Neuroendocrine
neoplasms of the gut and pancreas: new insights. Nat Rev
Endocrinol. 8:54–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heim S and Mitelman F: Cancer
Cytogenetics. 3rd edition. Wiley-Blackwell; NJ: 2009
|
|
8
|
Capurso G, Festa S, Valente R, Piciucchi
M, Panzuto F, Jensen RT and Delle Fave G: Molecular pathology and
genetics of pancreatic endocrine tumours. J Mol Endocrinol.
49:R37–R50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitelman F, Johansson B and Mertens F:
Mitelman database of chromosome aberrations and gene fusion in
cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
2014
|
|
10
|
Bugalho MJ, Roque L, Sobrinho LG, Hoog A,
Nunes JF, Almeida JM, Leitão CN, Santos JR, Pereira MC and Santos
MA: Calcitonin-producing insulinoma: clinical, immunocytochemical
and cytogenetical study. Clin Endocrinol (Oxf). 41:257–260. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Long PP, Hruban RH, Lo R, Yeo CJ,
Morsberger LA and Griffin CA: Chromosome analysis of nine endocrine
neoplasms of the pancreas. Cancer Genet Cytogenet. 77:55–59. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scappaticci S, Brandi ML, Capra E,
Cortinovis M, Maraschio P and Fraccaro M: Cytogenetics of multiple
endocrine neoplasia syndrome. II. Chromosome abnormalities in an
insulinoma and a glucagonoma from two subjects with MEN1. Cancer
Genet Cytogenet. 63:17–21. 1992.PubMed/NCBI
|
|
13
|
Floridia G, Grilli G, Salvatore M,
Pescucci C, Moore PS, Scarpa A and Taruscio D: Chromosomal
alterations detected by comparative genomic hybridization in
nonfunctioning endocrine pancreatic tumors. Cancer Genet Cytogenet.
156:23–30. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Speel EJ, Scheidweiler AF, Zhao J, Matter
C, Saremaslani P, Roth J, Heitz PU and Komminoth P: Genetic
evidence for early divergence of small functioning and
nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an
early event in insulinomas. Cancer Res. 61:5186–5192.
2001.PubMed/NCBI
|
|
15
|
Terris B and Bernheim A: Comparative
genomic hybridization (CGH): application to the study of
neuroendocrine tumors. Ann Pathol. 19(Suppl 5): S9–S11. 1999.(In
French).
|
|
16
|
Zhao J, Moch H, Scheidweiler AF, Baer A,
Schaffer AA, Speel EJ, Roth J, Heitz PU and Komminoth P: Genomic
imbalances in the progression of endocrine pancreatic tumors. Genes
Chromosomes Cancer. 32:364–372. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Boninsegna L, Panzuto F, Partelli S,
Capelli P, Delle FG, Bettini R, Pederzoli P, Scarpa A and Falconi
M: Malignant pancreatic neuroendocrine tumour: lymph node ratio and
Ki67 are predictors of recurrence after curative resections. Eur J
Cancer. 48:1608–1615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Haugvik SP, Marangos IP, Røsok BI,
Pomianowska E, Gladhaug IP, Mathisen O and Edwin B: Long-term
outcome of laparoscopic surgery for pancreatic neuroendocrine
tumors. World J Surg. 37:582–590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mandahl N: Methods in solid tumors. Human
Cytogenetics: A Practical Approach. Vol II: Malignancy and Acquired
Abnormalities. Rooney DE and Czepulkowski BH: IRL Press, Oxford
University Press; UK: pp. 155–187. 1992
|
|
20
|
Kallioniemi A, Kallioniemi OP, Sudar D,
Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic
hybridization for molecular cytogenetic analysis of solid tumors.
Science. 258:818–821. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Micci F, Teixeira MR, Haugom L, Kristensen
G, Abeler VM and Heim S: Genomic aberrations in carcinomas of the
uterine corpus. Genes Chromosomes Cancer. 40:229–246. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Micci F, Haugom L, Ahlquist T, Andersen
HK, Abeler VM, Davidson B, Trope CG, Lothe RA and Heim S: Genomic
aberrations in borderline ovarian tumors. J Transl Med. 8:212010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Speel EJ, Richter J, Moch H, Egenter C,
Saremaslani P, Rutimann K, Zhao J, Barghorn A, Roth J, Heitz PU and
Komminoth P: Genetic differences in endocrine pancreatic tumor
subtypes detected by comparative genomic hybridization. Am J
Pathol. 155:1787–1794. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jonkers YM, Claessen SM, Perren A, Schmid
S, Komminoth P, Verhofstad AA, Hofland LJ, de Krijger RR, Slootweg
PJ, Ramaekers FC and Speel EJ: Chromosomal instability predicts
metastatic disease in patients with insulinomas. Endocr Relat
Cancer. 12:435–447. 2005. View Article : Google Scholar : PubMed/NCBI
|
